Cash & equivalents decreased 32.2%
Cash & equivalents changed -32.2% from the comparable as-filed period.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Cash & equivalents changed -32.2% from the comparable as-filed period.
Gross margin changed +17420 basis points from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Gross profit changed -207.1% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Net income changed -207.6% from the comparable as-filed period.
Operating income changed -191.8% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Operating margin changed +148680 basis points from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Research & development changed +122.4% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Revenue changed +404.4% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Stock-based compensation changed +233.9% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.